Interstitial Cystitis Market Key Drivers, Trends, Growth, Outlook 2024-2033

The interstitial cystitis market size has grown strongly in recent years. It will grow from $1.69 billion in 2023 to $1.83 billion in 2024 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to advancements in diagnosis, awareness and education, pharmaceutical developments, supportive therapies.

The interstitial cystitis market size is expected to see strong growth in the next few years. It will grow to $2.53 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to biomarker research, innovative medications, patient-centered care, global expansion. Major trends in the forecast period include dietary guidance, interdisciplinary care, research collaboration, alternative therapies.

Market Overview -
Interstitial cystitis (IC) is a chronic condition that causes bladder pain and pressure that can be mild or severe and can be constant or come and go. It is characterized by pain, stress, or discomfort associated with the urinary bladder that lasts more than six months. The use of tricyclic antidepressants, antihistamines and bladder instillations can help relieve pain and reduce inflammation.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13041&type=smp

Surging Urinary Tract Infections Fuel Growth In The Interstitial Cystitis Market
The rising prevalence of urinary tract infections is expected to propel the growth of the interstitial cystitis market. Urinary tract infections are bacterial infections that can occur anywhere in the urinary system and are caused by bacteria that enter the urethra. UTI can induce bacterial cystitis directly or indirectly and untreated UTI can lead to persistent bladder inflammation, the underlying cause of interstitial cystitis. Treatment for urinary tract infections caused by interstitial cystitis improves pain alleviation and quality of life in patients suffering from the disease. For instance, in 2021, according to the Centers for Disease Control and Prevention, a US-based national public health agency, in the US there were around 24,710 catheter-associated urinary tract infections reported in 2021. Further, according to an article published by The British Society for Antimicrobial Chemotherapy, a UK-based multi-professional organization, estimated that almost half of all women in the United Kingdom will get at least one urinary tract infection (UTI) at some point in their lives. Therefore, the rising prevalence of urinary tract infections drives the interstitial cystitis market.

Competitive Landscape -
Major players in the interstitial cystitis market are Pfizer Inc., Johnson & Johnson Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline PLC, Takeda Pharmaceutical Co. Ltd., Eli Lilly and Company, Boehringer Ingelheim international GmbH, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Perrigo Company PLC, Aurobindo Pharma Ltd., Purdue Pharma LP, Apotex Inc., Endo International PLC, Amneal Pharmaceuticals Inc., Alvogen Inc., Kyorin Pharmaceutical Co. Ltd., Seikagaku Corp, Genentech Inc., Strides Pharma Science Limited, AlgoTherapeutix SAS.

Innovative Intravesical Solutions Revolutionize Interstitial Cystitis Treatment Market
Major companies operating in the interstitial cystitis treatment market are focused on developing innovative products, such as intravesical solutions, to treat interstitial cystitis and drive revenues in the market. Innovative treatments, such as interstitial cystitis intravesical solution, enhance the care and outcomes of this chronic and frequently complex bladder illness. For instance, in April 2021, Kyorin Pharmaceutical Co Ltd., a Japan-based developer and manufacturer of prescription medicines and quasi-drugs, launched Interstitial cystitis Zymso Intravesical Solution 50%, a dimethyl sulfoxide (DMSO) bladder instillation. It is uniquely designed with DMSO. Zymso is injected into the bladder through a catheter intended to relieve pain and discomfort associated with IC. The dosage for adults is six injections of 50 mL of 50% (w / w) dimethyl sulfoxide solution (27g of dimethyl sulfoxide) into the bladder spaced by two weeks.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/interstitial-cystitis-global-market-report

Key Segments -
The interstitial cystitis market covered in this report is segmented -
1) By Treatment: Medications; Bladder Instillation; Botulinum Toxin A; Nerve Stimulation; Surgery
2) By Patient Type: Pediatric Patients; Adult Patients
3) By Drug Type: Over-The-Counter (OTC) Drugs; Prescription Drugs
4) By End User: Hospitals And Clinics; Homecare

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

"Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

"Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps"

This release was published on openPR.